Aytu Biopharma (AYTU) Invested Capital (2011 - 2026)
Aytu Biopharma (AYTU) posted quarterly Invested Capital of $1.9 million for Q1 2026, little changed year-over-year from $1.9 million in Q1 2025, and down 79.54% quarter-over-quarter from $9.1 million in Q4 2025.
Aytu Biopharma (AYTU) Invested Capital (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Invested Capital for 15 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital changed 0.0% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $21.9 million (up 110.54% YoY), while the FY2025 annual figure was $9.1 million, up 278.41% from the prior year.
- Invested Capital slipped to $1.9 million in Q1 2026 per AYTU's latest filing, from $9.1 million in the prior quarter.
- Across five years, Invested Capital topped out at $9.1 million in Q4 2025 and bottomed at $62000.0 in Q3 2023.
- Historically, Invested Capital has averaged $3.1 million across 5 years, with a median of $1.9 million in 2024.
- Annual changes were most pronounced in 2023 — Invested Capital plunged 99.23% — and 2024, when it surged 6787.1%.
- Aytu Biopharma's Invested Capital stood at $90000.0 in 2022, then surged by 1040.0% to $1.0 million in 2023, then surged by 80.99% to $1.9 million in 2024, then surged by 388.69% to $9.1 million in 2025, then plunged by 79.54% to $1.9 million in 2026.
- Business Quant data shows AYTU's Invested Capital at $1.9 million in Q1 2026, $9.1 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 630.00 Mn |
| 10 | Aytu Biopharma | 24.49 Mn | -2.22 Mn | 7.60 Mn | 10.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.86 Mn |
| Dec 31, 2025 | 9.08 Mn |
| Sep 30, 2025 | 1.86 Mn |
| Jun 30, 2025 | 9.06 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 4.27 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 1.03 Mn |
| Sep 30, 2023 | 62,000.00 |
| Jun 30, 2023 | 1.56 Mn |
| Mar 31, 2023 | 3.31 Mn |
| Dec 31, 2022 | 90,000.00 |
| Sep 30, 2022 | 8.09 Mn |
| Jun 30, 2022 | 3.81 Mn |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 1.21 Mn |
| Sep 30, 2021 | 4.52 Mn |
| Jun 30, 2021 | 16.67 Mn |